المؤلفون: Poli, D., Antonucci, E., Pengo, V., Migliaccio, L., Testa, S., Lodigiani, C., Coffetti, N., Facchinetti, R., Serricchio, G., Falco, P., Mangione, C., Masottini, S., Ruocco, L., De Caterina, R., Palareti, G., Italian Federation of Anticoagulation Clinics

مصطلحات موضوعية: Male, medicine.medical_specialty, medicine.drug_class, Hemorrhage, 030204 cardiovascular system & hematology, Mechanical heart valves, 03 medical and health sciences, Anticoagulation, 0302 clinical medicine, Postoperative Complications, Risk Factors, Internal medicine, Thromboembolism, Outcome Assessment, Health Care, medicine, Humans, In patient, Bleeding, Stroke, Vitamin K antagonists, 030212 general & internal medicine, International Normalized Ratio, Blood Coagulation, Prosthetic heart, Aged, Retrospective Studies, Heart Valve Prosthesis Implantation, business.industry, Anticoagulants, Atrial fibrillation, Retrospective cohort study, Vitamin K antagonist, Middle Aged, medicine.disease, Thromboembolic risk, Italy, Heart Valve Prosthesis, Cardiology, Observational study, Female, Warfarin, Drug Monitoring, Cardiology and Cardiovascular Medicine, business, Platelet Aggregation Inhibitors

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::59ba0ce49b30e443697efe9216f6845e
http://hdl.handle.net/11562/984050

لا يتم عرض هذه النتيجة على الضيوف.
تسجيل الدخول للوصول الكامل.

لا يتم عرض هذه النتيجة على الضيوف.
تسجيل الدخول للوصول الكامل.

لا يتم عرض هذه النتيجة على الضيوف.
تسجيل الدخول للوصول الكامل.

المؤلفون: Poli D; Thrombosis Centre, Azienda Ospedaliero-Universitaria Careggi, Florence, Italy. Electronic address: polida@aou-careggi.toscana.it., Antonucci E; Arianna Anticoagulazione Foundation, Bologna, Italy., Pengo V; Department of Cardiac Thoracic and Vascular Sciences, Thrombosis Centre, University of Padova, Italy., Migliaccio L; Arianna Anticoagulazione Foundation, Bologna, Italy., Testa S; Haemostasis and Thrombosis Centre, Hospital of Cremona Italy., Lodigiani C; Humanitas Research Hospital, IRCCS Rozzano-Milano, Italy., Coffetti N; Immunoematologia e Medicina Trasfusionale Azienda Ospedaliera Bolognini, ASST Bergamo Est, Seriate, Italy., Facchinetti R; Laboratorio Analisi (AOUI) Ospedale Civile Maggiore Di Borgo Trento, Verona, Italy., Serricchio G; Centro TAO PO Cantù, ASST Lariana, Como, Italy., Falco P; Poliambulatorio Specialistico Medical Pontino, Latina, Italy., Mangione C; Servizio Immunotrasfusionale Ospedale 'Santa Caterina Novella', Galatina (Le), Italy., Masottini S; Centro per la prevenzione, diagnosi e trattamento delle malattie tromboemboliche- Asl 8- Cagliari, Italy., Ruocco L; Ambulatorio Antitrombosi CAT-TAO AOU Pisana, Pisa, Italy., De Caterina R; Institute of Cardiology and Center of Excellence on Aging - 'G. d'Annunzio' University - Chieti, Italy., Palareti G; Arianna Anticoagulazione Foundation, Bologna, Italy.

مؤلفون مشاركون: Italian Federation of Anticoagulation Clinics

المصدر: International journal of cardiology [Int J Cardiol] 2018 Sep 15; Vol. 267, pp. 68-73.

نوع المنشور: Journal Article; Multicenter Study; Observational Study

بيانات الدورية: Publisher: Elsevier Country of Publication: Netherlands NLM ID: 8200291 Publication Model: Print Cited Medium: Internet ISSN: 1874-1754 (Electronic) Linking ISSN: 01675273 NLM ISO Abbreviation: Int J Cardiol Subsets: MEDLINE

مواضيع طبية MeSH: Heart Valve Prosthesis Implantation*/adverse effects , Heart Valve Prosthesis Implantation*/instrumentation , Heart Valve Prosthesis Implantation*/methods , Hemorrhage*/chemically induced , Hemorrhage*/epidemiology , Hemorrhage*/prevention & control , Postoperative Complications*/diagnosis , Postoperative Complications*/etiology , Postoperative Complications*/prevention & control , Thromboembolism*/diagnosis , Thromboembolism*/epidemiology , Thromboembolism*/etiology , Thromboembolism*/prevention & control , Warfarin*/administration & dosage , Warfarin*/adverse effects, Blood Coagulation/*drug effects, Aged ; Anticoagulants/administration & dosage ; Anticoagulants/adverse effects ; Drug Monitoring/methods ; Female ; Heart Valve Prosthesis ; Humans ; International Normalized Ratio ; Italy/epidemiology ; Male ; Middle Aged ; Outcome Assessment, Health Care ; Platelet Aggregation Inhibitors/administration & dosage ; Platelet Aggregation Inhibitors/adverse effects ; Retrospective Studies ; Risk Factors